CNNM4, which is upregulated in NAFLD patients, has been described as a master regulator of VLDL export in this pathology, mediated by activation of the microsomal transfer protein found in the ER29. The gene discussed is CNNM4; the disease is metabolic dysfunction-associated steatotic liver disease.